Shalby Ltd (NSE: SHALBY, BSE: 540797) is an Ahmedabad, Gujarat-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹1,350 Cr, it ranks #1,437 by market cap among the 6,197 Indian listed companies on FinBizNet, and #21 of 46 in Hospitals and Healthcare Centers. At ₹123.62 (as of 16 Nov 2026), the share price is 45.7% below its 52-week high of ₹227.66 and 11.8% above its 52-week low of ₹110.61. The share price is down 47.3% over one year and down 20.6% over three months.
| Current Price | ₹123.62 |
|---|---|
| Market Cap | ₹1,350 Cr |
| NSE Symbol | SHALBY |
| BSE Code | 540797 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 36.7 |
| Return on Equity | 3.47% |
| Return on Assets | 2.83% |
| 52-Week Range | ₹110.61 – ₹227.66 |
| 1-Year Price Change | -47.3% |
| 3-Month Price Change | -20.6% |
| Beta (1Y) | 0.5 |
| Dividend Yield | 0.00% |
| Headquarters | Ahmedabad, Gujarat |
| Website | www.shalby.org |
| Revenue | ₹313 Cr |
|---|---|
| Net Profit | ₹8 Cr |
| Net Margin | 2.5% |
| EPS (Basic) | ₹0.73 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Shalby Ltd reported revenue of ₹313 Cr in Q2 FY27, up 9.7% from ₹285 Cr in Q2 FY26 and down 5.4% from ₹331 Cr in Q1 FY27. It posted a net profit of ₹8 Cr for the quarter, against a net profit of ₹7 Cr in Q2 FY26 (up 8.4%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹265 Cr (Q4 FY25) to ₹331 Cr (Q1 FY27). The company reported a net loss in 1 of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹313 Cr | ₹8 Cr | 2.5% |
| Q1 FY27 | ₹331 Cr | ₹11 Cr | 3.2% |
| Q4 FY26 | ₹287 Cr | ₹18 Cr | 6.4% |
| Q3 FY26 | ₹272 Cr | ₹1 Cr | 0.5% |
| Q2 FY26 | ₹285 Cr | ₹7 Cr | 2.6% |
| Q1 FY26 | ₹296 Cr | ₹8 Cr | 2.6% |
| Q4 FY25 | ₹265 Cr | −₹12 Cr | −4.6% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 74.33% of Shalby Ltd's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 60.5% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology services; root canal treatment, dental implants, crowns bridges, dentures, orthodontic treatment, dental cosmetic, teeth whitening, pediatric dentistry, dental veneers, gum treatment, and laser dentistry; dermatology; emergency and general medicine; cochlear implants and balloon sinuplasty; gastroenterology, obesity surgery, and endoscopy and laparoscopy; intensive and critical care; nephrology, urology, kidney transplant, dialysis, and interventional nephrology; and general surgery comprising varicose, hernia, and piles surgery. The company also provides liver transplant; maxillofacial surgery; neur
1. Manufacturing of Implants-This segment manufactures implants. 2. Healthcare Services-This segment engages in setting up and managing hospitals and medical diagnostic services. 3. Segment Adjustment-0
1. Healthcare Services-88.5% 2. Manufacturing & Trading of Implants-11.5%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,23,712 Cr | 63 | 21.50% | ₹7,615 Cr | +11.6% |
| Max Healthcare Institute Ltd | ₹91,978 Cr | 63.9 | 14.33% | ₹2,569 Cr | -16.6% |
| Manipal Health Enterprises Ltd | ₹89,110 Cr | 88.4 | — | ₹3,399 Cr | — |
| Aster Dm Healthcare Limited (Asterdm) | ₹63,041 Cr | 97.6 | 10.07% | ₹2,829 Cr | +4.3% |
| Fortis Healthcare Ltd. | ₹58,283 Cr | 55.1 | 11.01% | ₹2,735 Cr | -25.1% |
| Global Health Ltd (Medanta) | ₹38,422 Cr | 69.7 | 15.03% | ₹1,469 Cr | +16.2% |
| Narayana Hrudayalaya Limited | ₹37,907 Cr | 46.2 | 19.85% | ₹2,844 Cr | +2.8% |
| Krishna Institute Of Medical Science (KIMS) | ₹29,056 Cr | 120.6 | 9.72% | ₹1,344 Cr | +0.2% |
| Shalby Ltd | ₹1,350 Cr | 36.7 | 3.47% | ₹313 Cr | -47.3% |
Listed by market capitalisation. Ratios are shown for context only.
Shalby Ltd is trading at ₹123.62, with a market capitalisation of ₹1,350 Cr.
Shalby Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Shalby Ltd has a P/E of 36.7 and a return on equity of 3.47%.
Shalby Ltd is listed on the NSE under the symbol SHALBY and on the BSE under the scrip code 540797.
Shalby Ltd's share price is down 47.3% over one year and down 20.6% over three months. Its 52-week range is ₹110.61 to ₹227.66.
In Q2 FY27, Shalby Ltd reported revenue of ₹313 Cr and net profit of ₹8 Cr, with basic EPS of ₹0.73 (consolidated, parsed from the company's exchange filing).
Shalby Ltd reported revenue of ₹313 Cr in Q2 FY27, up 9.7% from ₹285 Cr in Q2 FY26 and down 5.4% from ₹331 Cr in Q1 FY27.
Promoters held 74.33% of Shalby Ltd's shares as of Sept 2026, unchanged from Sept 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.